MHRA Guidelines for Pregnancy Acid Reflux Treatment
Understanding Acid Reflux in Pregnancy
Pregnancy-related acid reflux occurs due to hormonal changes and physical pressure from the growing baby. Progesterone relaxes the lower oesophageal sphincter, whilst the expanding uterus pushes stomach contents upward. The MHRA recognises that effective treatment may be necessary when lifestyle modifications prove insufficient.
Safe Medication Options During Pregnancy
Omeprazole is classified as pregnancy category C, meaning studies show no harm in animal reproduction studies. The MHRA considers omeprazole generally safe during pregnancy when benefits outweigh potential risks. EverydayMeds offers Omeprazole 20mg Capsules and Losec MUPS 20mg for pregnancy-related reflux management. Lansoprazole 15mg Capsules provide an alternative PPI option with similar safety profiles.
When to Seek Treatment
Consider medication when experiencing frequent heartburn (more than twice weekly), sleep disruption, or when symptoms interfere with daily activities. Severe reflux can affect nutritional intake, potentially impacting fetal development. Healthcare providers may recommend starting with the lowest effective dose.
Dosage During Pregnancy
Standard pregnancy dosing typically begins with omeprazole 20mg once daily, taken before breakfast. Some women may require pantoprazole 20mg or esomeprazole as alternatives. Famotidine tablets offer an H2 blocker option for those preferring non-PPI treatments. Treatment duration should be the shortest period necessary for symptom control.
Monitoring and Safety
Regular monitoring ensures optimal treatment outcomes whilst minimising potential risks. The MHRA recommends periodic review of continued necessity, particularly during the third trimester. Most women can safely continue PPI therapy throughout pregnancy when medically indicated. EverydayMeds provides comprehensive medication information to support informed treatment decisions.
